🔴 Critical Risk

PAVM: PAVmed Inc.
Dilution Risk Score 89/100

PAVmed Inc. (PAVM) carries a Critical dilution risk score of 89 out of 100 based on DilutionWatch's real-time analysis of SEC EDGAR filings. Contributing factors include convertible securities representing 803% of current share count.

Why PAVM Has a Critical Dilution Risk Score

DilutionWatch scores every ticker on a 0–100 scale by analyzing five components: cash runway, warrant overhang, convertible securities, active shelf/ATM capacity, and historical filing patterns. A score of 89 means PAVM is in the highest-risk category across multiple dimensions simultaneously.

• Cash runway: Estimated at 3.4 months — limited, increasing pressure to raise additional capital in the near term
• Warrant overhang: Outstanding warrants represent 82% of current shares outstanding — significant potential dilution if exercised at or near current prices
• Convertible securities: Convertible notes/instruments represent 803% of current shares — creating extreme dilution risk if converted
• Filing pattern: 5 dilutive filings in the past 12 months (last: 2025-04-21), indicating a pattern of repeat capital raises

Recent SEC Filing History for PAVM

The following dilutive filings have been detected for PAVM in the past 12 months via DilutionWatch's real-time EDGAR monitoring:

How to Monitor PAVM for Dilution Alerts

DilutionWatch polls SEC EDGAR every 60 seconds. When PAVmed Inc. files an S-3, 424B, 8-K financing disclosure, or any of 25 tracked filing types, you receive an alert before the stock reprices. This is the same monitoring capability that institutional traders use — available to retail investors through DilutionWatch's free tier.